3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Neoplasms
5
Lung Neoplasms
5
Brain Neoplasms
3
Prostatic Neoplasms
2
Esophageal Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Thoracic Neoplasms
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasms by Site
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphoma
1
Lung Diseases
1
Gastric Adenocarcinoma
1
Detection Rate of SLN ; Accuracy Rate of Lymph Node Metastasis
1
Breast Neoplasms
1
Interventions
osimertinib
3
entinostat
3
Pemetrexed
2
Carboplatin
2
sotorasib
1
pembrolizumab
1
exemestane
1
Tyrosine Kinase Inhibitors
1
Sunitinib
1
Indocyanine Green
1
Erlotinib Hydrochloride
1
Dasatinib
1
Afatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Thoracic Neoplasms
×
Indocyanine Green
×
Clear all
NCT02111824
2021-09-17
MIMIG
The Methodist Hospital Research Institute
Phase 1
Terminated
7 enrolled